DePuy Entering Spinal Fusion Cage Market With $325 Mil. AcroMed Purchase
This article was originally published in The Gray Sheet
Executive Summary
DePuy is looking to establish itself as a player in the expanding spinal fusion cage market - currently estimated at $120 mil. and growing rapidly - through the acquisition of AcroMed for $325 mil. The Roche subsidiary announced the cash offer on March 20.